-
Banff Avenue Transforms into High-End Retail Hub Amid Local Business Concerns
-
Selena Gomez Launches Black Equality Fund to Support Racial Justice Organizations
-
First Canadian Graphite Reports 43.9% Graphitic Carbon Sample and Encouraging Coarse-Flake Characteristics at Zone 13 at Lac Guéret South
-
LASE to Premiere Quantum Bullet(TM) at Counter UAS Technology Conference in Washington, D.C.
-
American Critical Minerals Reports High Grade Potash Intersection of 6.55m Grading 38.51 wt.% KCl at its Green River Project, Utah
-
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 19
-
Bob's Watches Founder Paul Altieri Unveils Private Collection of Vintage Rolex Watches in New Book, "NOT FOR SALE"
-
Making the Most of a Long Weekend Without Leaving Town
-
India Imposes 162.5% Duty on Bulk Scotch Imports Amid UK Trade Pact Dispute
-
GTA 6 Release Date Confirmed for November 19; Troubleshooting Pre-load and Launch Errors
-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
Ryan Confer, President and Chief Executive Officer of Genprex, Inc., to Present at Investor Summit Virtual on September 16, 2025
AUSTIN, TX / ACCESS Newswire / September 10, 2025 / Genprex, Inc.'s President and Chief Executive Officer, Ryan Confer, will present at the Investor Summit Virtual on September 16, 2025, offering investors an inside look at the company's growth strategies and market opportunities.
About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
Event Details
Event: Q3 Investor Summit
Presentation Date & Time: September 16 | 2:00 PM ET
Location: Webcast Link
Conference Overview and Structure
The Investor Summit is an exclusive virtual event for investors specializing in small and microcap stocks. Attendees will:
Hear directly from company executives about key strategies and milestones
Learn from industry experts and thought leaders
Explore opportunities in the microcap market
This quarter's event emphasizes undervalued MicroCap companies with strong growth catalysts, providing investors with a unique platform for discovery and engagement.
Investor Registration:
Investors can register for free using the link below: https://investorsummitgroup.fillout.com/t/8CZGk3gSQbus
Sponsors:
ACCESS Newswire | PCG Advisory | QuoteMedia | AGP | MZ Group
Media Contact:
For more information, please visit https://investorsummitgroup.com/ or contact [email protected]
SOURCE: Genprex, Inc.
View the original press release on ACCESS Newswire
R.Garcia--AT